APA (7th ed.) Citation

Piekarska, A., Abouqateb, M., Boreland, W., Peczynski, C., Zaucha, J. M., Kröger, N., . . . Peric, Z. (2025). Improved GVHD-free relapse-free survival when rATG/ATLG is used in allo-HCT from matched sibling donors: An EBMT registry study by the Transplant Complications Working Party. Bone marrow transplantation, 60(12), . https://doi.org/10.1038/s41409-025-02692-1

Chicago Style (17th ed.) Citation

Piekarska, Agnieszka, et al. "Improved GVHD-free Relapse-free Survival When RATG/ATLG Is Used in Allo-HCT from Matched Sibling Donors: An EBMT Registry Study by the Transplant Complications Working Party." Bone Marrow Transplantation 60, no. 12 (2025). https://doi.org/10.1038/s41409-025-02692-1.

MLA (9th ed.) Citation

Piekarska, Agnieszka, et al. "Improved GVHD-free Relapse-free Survival When RATG/ATLG Is Used in Allo-HCT from Matched Sibling Donors: An EBMT Registry Study by the Transplant Complications Working Party." Bone Marrow Transplantation, vol. 60, no. 12, 2025, https://doi.org/10.1038/s41409-025-02692-1.